What Is 5-Amino-1MQ? NNMT Inhibitor Research Overview

5-Amino-1MQ appears in almost every metabolic research catalog, usually listed next to peptides — which is the first source of confusion about it. It is not a peptide. 5-Amino-1-methylquinolinium is a small organic molecule that inhibits an enzyme, nicotinamide N-methyltransferase (NNMT), and it is studied for what that enzyme does to a cell's NAD+ supply and methyl-donor balance. This overview covers what 5-amino-1MQ is, how it works at the enzyme level, and what cell-model and animal-model research examines. For in-vitro laboratory research only.

What is 5-amino-1MQ?

5-Amino-1MQ is short for 5-amino-1-methylquinolinium. Its core is a quinoline ring system — two fused six-membered rings, one of them containing nitrogen — with a methyl group on that ring nitrogen and an amino group at the 5-position. Methylating the ring nitrogen gives it a permanent positive charge, so the compound is a quinolinium cation that always travels with a counter-ion. It came out of medicinal-chemistry work that screened a series of quinolinium analogs for their ability to block NNMT, and it is described in that literature as a selective, membrane-permeable NNMT inhibitor. The 5-amino-1MQ research compound is supplied lyophilized in 5mg research vials.

Is 5-amino-1MQ a peptide?

No, and the distinction matters for how it is studied. Peptides are chains of amino acids joined by amide bonds, and most research peptides have molecular weights well above a thousand daltons. 5-Amino-1MQ has no amino-acid backbone at all: it is a single heterocyclic molecule with a molecular weight in the low hundreds. It acts on an intracellular enzyme rather than binding a cell-surface receptor the way the incretin peptides do.

5-Amino-1MQ iodide vs chloride

Because the quinolinium nitrogen carries a fixed positive charge, 5-amino-1MQ exists as a salt: the active cation paired with a negatively charged counter-ion. Iodide and chloride are two common counter-ions, so the iodide and chloride forms are two salts of the same cation, and the part that interacts with NNMT is identical in both. The counter-ion changes the molecular weight of the salt and can change handling properties such as solubility, which is why researchers record the salt form when converting mass to molar concentration.

What is NNMT?

Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that transfers a methyl group from S-adenosylmethionine (SAM) onto nicotinamide, a form of vitamin B3. The reaction yields 1-methylnicotinamide (often abbreviated MNA) and S-adenosylhomocysteine (SAH). NNMT is expressed most strongly in the liver and in adipose tissue, which is why fat cells (adipocytes) and liver-cell models feature so heavily in NNMT research. That single reaction connects two pathways central to cellular metabolism:

• NAD+ salvage — nicotinamide is the main substrate cells recycle to rebuild NAD+, and nicotinamide that NNMT methylates is no longer available for that route
• Methyl-donor balance — every NNMT reaction spends one molecule of SAM, the cell's universal methyl donor, and produces SAH; the SAM-to-SAH ratio is a standard readout of methylation capacity

How does 5-amino-1MQ work? Mechanism of action

5-Amino-1MQ is studied as an NNMT inhibitor: it reduces the enzyme's ability to methylate nicotinamide. The research hypothesis follows directly from the reaction above. With NNMT activity reduced, less nicotinamide is diverted into 1-methylnicotinamide and less SAM is spent on this route, so researchers measure whether more nicotinamide stays available for NAD+ salvage and whether the SAM pool shifts in turn.

The NAD+ salvage connection

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme in cellular energy metabolism and the substrate for NAD+-consuming enzymes such as the sirtuins. Cells recycle nicotinamide back into NAD+ through the salvage pathway, in which the enzyme NAMPT converts nicotinamide into nicotinamide mononucleotide (NMN). NNMT draws on the same nicotinamide pool. That is why 5-amino-1MQ research is so often read alongside NAD+ research: one compound is studied for reducing a drain on the nicotinamide pool, while NAD+ itself is studied as the coenzyme that pool feeds.

The methyl-donor connection

NNMT has been described in the research literature as a methylation sink: where it is highly expressed, it can consume a meaningful share of the cell's SAM. Because SAM also supplies the methyl groups for DNA and histone methylation, NNMT activity is studied as a link between metabolism and the epigenetic machinery. Inhibitor studies use compounds like 5-amino-1MQ to ask what happens to SAM levels, the SAM-to-SAH ratio, and methylation-dependent gene regulation when that sink is reduced.

What is 5-amino-1MQ studied for in research?

The published literature on 5-amino-1MQ is predominantly preclinical — cell-culture and animal-model work. Common research themes include:

• Cultured adipocyte models — how NNMT inhibition changes intracellular NAD+ and SAM levels and lipid-synthesis (lipogenesis) pathways in fat-cell lines
• Enzyme-selectivity studies — characterizing inhibition of NNMT relative to related methyltransferases and enzymes of the NAD+ salvage pathway
• Rodent metabolic models — including high-fat-diet mouse models, where NNMT activity in adipose tissue and liver is examined alongside energy-metabolism markers
• Skeletal-muscle and aging models — where the NNMT-NAD+ link has been examined in muscle stem-cell studies in older animals

These are mechanism questions, and the 5-amino-1MQ reference compound gives a laboratory a defined tool for asking them in a controlled model.

5-Amino-1MQ vs other metabolic research compounds

Comparison searches — 5-amino-1MQ vs SLU-PP-332, vs tesofensine, vs GLP-1 agonists — are best answered by mechanism class, because none of these compounds acts on the same target:

• 5-Amino-1MQ — a small-molecule inhibitor of an intracellular enzyme (NNMT)
• GLP-1-family agonists such as retatrutide — peptides that activate cell-surface incretin receptors; see GLP-1 research peptides explained
• SLU-PP-332 — a small molecule described in the literature as an agonist of the estrogen-related receptors (ERRs), a family of nuclear receptors
• Tesofensine — a small molecule studied as a monoamine reuptake inhibitor acting on neurotransmitter transporters
• MOTS-c — a mitochondrial-derived peptide studied in AMPK and cellular energy-sensing pathways

Each acts at a different node of metabolism, so a comparison only makes sense once the research question names the pathway. MOTS-c is the closest conceptual neighbor — both are studied as intracellular regulators of energy metabolism rather than receptor agonists — covered in what is MOTS-c. For the wider map, see best research peptides for metabolic studies.

How 5-amino-1MQ is supplied

Eon supplies 5-amino-1MQ as a lyophilized solid in 5mg research vials, shipped from our US facility with tracking and a printed lot number on each vial. For in-vitro work it is reconstituted before use with a diluent such as bacteriostatic water; the general method in how to reconstitute peptides applies to lyophilized small molecules too, and the 5-amino-1MQ reconstitution calculator returns concentration for each diluent volume. Order 5-amino-1MQ directly or browse the weight & metabolic category.